The length of life of liver cancer malignant tumor is mainly related to the stage of cancer, treatment and individual factors of patients, which should be analyzed on a case-by-case basis and should not be generalized. If the patient has early stage liver cancer, the survival time is generally more than 5 years if the patient is in good physical condition and actively takes surgery. If the patient is in the middle or late stage of liver cancer, the patient is unable to take surgical treatment and the specific survival time varies from person to person and cannot be specified. Treatment is mainly through interventional embolization and arterial infusion chemotherapy, argon helium knife local cryotherapy and sorafenib mesylate targeted drug therapy to control disease progression. If patients cannot tolerate further radiotherapy and are given nutritional support therapy only, the survival period is usually very short and may not exceed 1 year. Therefore, patients with hepatocellular carcinoma are recommended to visit the medical oncology department of regular hospitals in a timely manner, so that professional doctors can formulate practical treatment plans according to patients’ individual conditions to improve their quality of life and prolong their survival.